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Objective: Smoking has been associated with a reduced risk of hip and knee osteoarthritis and 
subsequent joint replacement. The aim of the present study was to assess whether the 
observed association is likely to be causal. 
Method: 55 745 participants of a population-based cohort were genotyped for the rs1051730 
C>T single-nucleotide polymorphism, a proxy for smoking quantity among smokers.             
A Mendelian randomization analysis was performed using rs1051730 as an instrument to 
evaluate the causal role of smoking on the risk of hip or knee replacement (combined as total 
joint replacement (TJR)). Association between rs1051730 T alleles and TJR was estimated by 
hazard ratios (HRs) and 95% confidence intervals (CIs). All analyses were adjusted for age 
and sex. 
Results: Smoking quantity (no. of cigarettes) was inversely associated with TJR (HR 0.97, 
95% CI 0.97-0-98). In the Mendelian randomization analysis, rs1051730 T alleles were 
associated with reduced risk of TJR among current smokers (HR 0.84, 95% CI 0.76 to 0.98, 
per T allele), however we found no evidence of association among former (HR 0.97, 95% CI 
0.88 to 1.07) and never smokers (HR 0.97, 95% CI 0.89 to1.06). Neither adjusting for body 
mass index, cardiovascular disease nor accounting for the competing risk of mortality 
substantially changed the results. 
Conclusion: This study suggests that smoking may be causally associated with the reduced 
risk of TJR. Our findings add support to the inverse association found in previous 
observational studies. More research is needed to further elucidate the underlying mechanisms 
of this causal association. 




Hip and knee osteoarthritis (OA) are one of the leading causes of global disability and the 
burden of OA is anticipated to increase due to an aging and more obese population 1. No 
curative treatment for OA is available, which places emphasis on identifying modifiable risk 
factors for disease prevention and treatment of early OA 2. The results of observational studies 
suggest that smoking could have a protective effect on the development of OA 3,4 and 
subsequent hip and knee replacement 5-7. Although results from in vitro data have indicated a 
beneficial effect of nicotine on chondrocyte function, the mechanisms remain unclear 8,9. The 
question remains; is there a causal effect of smoking on OA? Observational studies are prone 
to confounding and reverse causality; hence, it is difficult to infer causal links between 
smoking and OA or joint replacement using information from observational studies alone. 
In Mendelian randomisation analysis, the causality of epidemiological relationships is 
investigated using genetic variants as proxies for the exposure of interest. Due to the random 
assortment of genetic variants at conception, genetic variants tend to be independent of 
potential confounders. Hence, genotypes associated with smoking are not likely to be 
associated with environmental factors that may confound conventional observational studies 
10. The C>T single-nucleotide polymorphism (SNP) rs1051730 in the CHRNA5- CHRNA3- 
CHRNB4 nicotinic acetylcholine receptor gene cluster on chromosome 15 is the strongest 
genetic contributor to smoking behavior identified in genome-wide association studies to date 
11-13. Each additional T allele at the rs1051730 SNP is associated with an increase in the 
number of cigarettes smoked per day and increased cotinine levels, a metabolite of nicotine, 
among current smokers 14. The rs1051730 SNP has been used as an instrument for smoking 
intensity in former Mendelian randomisation studies investigating the causal effect of 
cigarette smoking on body mass index (BMI), anxiety and depression and cardiovascular risk 
factors 15-19.  
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We are not aware of studies using the rs1051730 SNP to study the association between 
smoking and OA, or hip or knee replacement. Thus, the aim of the present study was to 
investigate whether the association observed between smoking and hip or knee replacement is 





The Nord-Trøndelag Health Study (HUNT) is a population-based study with data collected 
through three cross-sectional surveys; HUNT1 (1984-1986), HUNT2 (1995-1997) and 
HUNT3 (2006-2008). The surveys comprise data from questionnaires, interviews, clinical 
examinations and blood sampling. All residents of Nord-Trøndelag County, Norway aged 20 
years and older were invited to participate. The HUNT study has been described in detail 
elsewhere 20,21. For the present study, we included participants from HUNT2; in which 65 232 
(69.5% of those invited) participated. Of these, 56 625 participants were successfully 
genotyped for the rs1051730 SNP. A total of 880 participants were excluded because of hip or 
knee replacement prior to baseline in HUNT2 (n=503), no date recorded for the primary hip 
or knee replacement (n=25), missing information on age at participation (n=3), or 
death/emigration before start of follow-up (n=2). Current smokers of only pipes and cigars, 
but not cigarettes, were also excluded (n=347). Our study sample therefore comprised 55 745 
participants. The current study was approved by the Regional Committees for Medical and 






DNA was extracted from blood samples collected at baseline in HUNT2 and stored at the 
HUNT biobank. The rs1051730 SNP was genotyped at the HUNT biobank using a TaqMan 
assay (Assay ID: C_9510307_20, Applied Biosystems, USA) on an Applied Biosystems 
7900HT Fast Real-Time PCR System, as described in former HUNT studies 15,16. The call 
rate cut-off was set to 90%. The genotype was coded according to the number of T alleles 
(0=no T allele, 1=heterozygote for the T allele, 2=homozygote for the T allele). The 
genotyping success rate was 99.3% and the quality score for each individual genotype was > 
90 (mean 99.6). There was no evidence of departure from the Hardy-Weinberg equilibrium 
(χ2 test, p=0.26). The minor allele frequency was in agreement with HapMap-CEU data 
(MAF=0.335 and 0.389, respectively). 
 
Smoking 
Smoking status was self-reported in the HUNT2 questionnaire and categorised into never, 
former and current smokers. Current smokers were asked to report the average number of 
cigarettes smoked per day. Individuals, who reported being current smokers of pipes and 
cigars, but not cigarettes, were excluded from all analyses.  
 
Covariates 
Height and weight were measured by trained personnel. BMI is weight in kilograms divided 
by height in meters squared. Cardiovascular disease (CVD) was defined as a composite of 





The outcome of interest was the first hip or knee replacement due to primary OA. To retain 
statistical power, hip and knee replacements were combined to one variable; total joint 
replacement (TJR). The unique 11-digit identity numbers of Norwegian citizens enabled us to 
link individuals’ baseline data in HUNT2 with the corresponding prospective TJR data in the 
Norwegian Arthroplasty Register. The orthopaedic surgeon submits a standardized form to 
the register for each TJR performed, containing information about the diagnosis that lead to 
the TJR, any previous TJR or other operations performed in the joint, and the type of implant 
used. We censored TJRs secondary to injury (meniscal or ligamentous), rheumatoid arthritis, 
femoral neck fracture, congenital dysplasia, Perthes’ disease, epiphysiolysis, ankylosing 
spondylitis and osteonecrosis of the femoral head, amongst others. The completeness of 
reporting hip and knee replacement in the register is high (>95%) 23,24.  
 
Statistical analysis 
Descriptive statistics according to the number of rs1051730 T alleles were compared using a 
Chi-square test for categorical variables and a linear regression for continuous variables. A 
Cox proportional hazards model was used both for the observational and Mendelian 
randomisation analyses. Estimates were given as hazard ratios (HRs) with 95% confidence 
intervals (CIs). Follow-up began on the day of inclusion in HUNT2 and ended at the date of 
TJR due to primary OA, date of TJR for conditions other than primary OA, date of 
death/emigration (available from Statistics Norway), or the end of follow-up (December 31, 
2013), whichever came first. All analyses were adjusted for age as the time scale in addition 
to sex. The proportional hazards assumptions were tested by Schoenfeld residuals. No 
deviation from proportionality was detected. To illustrate the observational association 
between smoking quantity and risk of TJR, smoking quantity was expressed by a restricted 
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cubic spline with knots at 0, 10, 20, 30 and 40 cigarettes per day. Never and former smokers 
were assumed to smoke zero cigarettes a day and were used as the reference point.  
We used a multinomial logistic regression and a linear regression to estimate the 
association between rs1051730 T alleles and smoking status and between rs1051730 T alleles 
and smoking quantity, respectively. Further, in the Mendelian randomisation analysis, the 
association between rs1051730 T alleles and risk of TJR was examined as an overall 
association as well as in the strata of never, former and current smokers. If smoking heaviness 
is causally associated with TJR, we would expect the association to be strongest among 
current smokers and absent among never smokers. To assess the statistical evidence that the 
association between rs1051730 T alleles and TJR was modified by smoking, we included 
interaction terms between the rs1051730 T alleles and smoking status (examining interaction 
across strata of never, former or current smoking) and between current vs. never and former 
smokers combined (examining interaction with current smoking). Models with and without 
the interaction terms were compared using the likelihood ratio test. Moreover, carriers of 
rs1051730 T alleles may be less likely to quit smoking. Stratifying on current and former 
smokers could therefore introduce bias, by conditioning on an observed measure of exposure. 
We therefore repeated the analysis between the SNP and TJR in strata of never vs. ever 
smokers (current and former smokers combined). We assumed an additive genetic model, so 
risk estimates represent the HRs per additional copy of the T allele. 
In the sensitivity analyses, we adjusted for BMI (expressed as restricted cubic spline) 
as a possible mediator between smoking and TJR, and for CVD at baseline. Further, we 
calculated subhazard ratios (SHRs) according to the Fine and Grey model 25 to account for the 
competing risk of mortality, since smoking is strongly associated with mortality. The 
proportional subhazard assumption was tested by introducing a time-varying 
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coefficient/interaction with time (tvc) to the model. Data were analysed using Stata v.14.1 




In total, 54 898 participants were genotyped for rs1051730 and had data on smoking status. 
This group included 16 705 (30.4%) current smokers, 15 350 (28.0%) former smokers and 22 
843 (41.6%) never smokers. In this sample, the number of TJRs during a follow-up 17.2 years 
(median) of was 2601 (4.7%). We found that as the number of T alleles increased, the 
participants tended to be slightly younger and have lower BMI. Among current smokers, 
rs1051730 T alleles were associated with a higher number of cigarettes smoked per day. 
Rs1051730 T alleles were not associated with any other characteristics (Table 1).  
 
Observational analysis 
We found an inverse association between smoking quantity and the risk of TJR (Fig. 1). The 
overall association (HR) between each additional cigarette smoked per day and TJR was 0.97 
(95% CI 0.97 to 0.98), p<0.001. 
 
Association of rs1051730 T alleles with smoking status and smoking quantity 
The genetic variant was associated with current smoking (odds ratio (OR) 1.08, 95% CI 1.05-
1.11) compared with never smoking, although there was no clear association with former 
smoking (OR 0.97, 95% CI 0.94-1.01) compared with never smoking. Similarly, in current 
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smokers, we found that each additional rs1051730 T allele was associated with an increase in 
the number of cigarettes smoked per day (0.66, 95% CI 0.54-0.79).  
 
Mendelian randomisation analysis 
In regard to smoking status, we found an inverse association between rs1051730 T alleles and 
TJR among current smokers, where each additional T allele was associated with a 16% 
reduction in the risk of TJR (HR 0.84, 95% CI 0.74 to 0.96) (Table 2). In contrast, there was 
no evidence of an association among never (HR 0.97, 95% CI 0.89 to 1.06) and former 
smokers (HR 0.97, 95% CI 0.88 to 1.07). The overall age- and sex-adjusted association (HR) 
between rs1051730 T alleles and risk of TJR was 0.93 (95% CI 0.89 to 1.00) (Table 2). There 
was no statistical evidence for effect measure modification across all strata of current, former 
and never smokers (p interaction=0.35), but there was indication of a greater effect per T 
allele among current smokers when compared to never and former smokers combined (p 
interaction=0.05). In the broader strata of never vs. ever smokers, rs1051730 T alleles were 
associated with reduced risk of TJR among ever smokers (HR 0.91, 95% CI 0.84 to 0.99).  
Adjustment for BMI had only a minor effect on the estimated association of 
rs1051730 T alleles with the risk of TJR in current smokers (HR 0.87, 95% CI 0.77 to 0.99) 
compared with the main result (Table 2). Adjustments for CVD did not change the results 
from the main analysis. The competing risk analysis, including all-cause mortality as the 
competing event to TJR, supported the main result of an inverse association between 
rs1051730 T alleles and the risk of TJR in current smokers (SHR 0.82, 95% CI 0.73 to 0.93) 






In this Mendelian randomisation analysis, we found support for a causal association between 
smoking and TJR. There was an inverse association between the number of cigarettes smoked 
per day and TJR, which was also evident between the rs1051730 SNP and TJR. We found 
that the risk of TJR among current smokers decreased with each additional copy of the T 
allele of the rs1051730. The lack of association among non-smokers offers further support to 
the notion that smoking is causally related to TJR. It indicates that, other than through 
smoking quantity, the rs1051730 T allele has no effect on the outcome 10. 
Our data adds support to previous observational studies which have suggested a 
negative association between smoking and TJR 5-7. In the Singapore Chinese Health Study 
current smokers compared with never smokers showed a dose-dependent inverse association 
between the numbers of cigarettes smoked and the risk of knee replacement 5. Similarly, after 
accounting for comorbidities and the competing risk of death, an Australian prospective 
cohort study found that current smokers were less likely to undergo a TJR than non-smokers 
6. Current smoking also reduced the likelihood of receiving TKR in a former Norwegian 
cohort study, however only among women 7. There is no clear biological explanation for an 
inverse association between smoking and OA, but one theory is related to the upregulation of 
glycosaminoglycan and collagen synthetic activity of articular chondrocytes as a direct effect 
of nicotine, something which has been shown in vitro 9. These findings have been replicated 
in a study on articular chondrocytes from OA patients 8. Another potential explanation is the 
indirect effect of smoking on lifestyle factors such as BMI. Increasing BMI is an established 
risk factor for OA and subsequent TJR 26,27 and there is evidence to suggest that smoking may 
lead to lower BMI 18,28,29, which could mediate the effect of smoking on TJR 30. However, the 
association of rs1051730 T alleles with TJR was only slightly attenuated after statistical 
adjustment for BMI.  
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Smoking greatly contributes to the total burden of disease, including CVD and chronic 
respiratory diseases 31,32. Moreover, smoking is an important risk factor for postoperative 
complications after TJR 33. In addition to smoking, older age, high BMI, and comorbidities 
have been presented as possible contraindications that could result in a decision against 
performing TJR 34,35, and these contra-indicators may potentially mediate the effect of 
smoking on TJR. In our study, adjustments for CVD at baseline did not change the association 
we found between the rs1051730 T allele and TJR. However, we did not have information on 
incident CVD during follow-up, or on other smoking-related diseases. Further, it is known 
that high smoking quantity leads to increased all-cause mortality 36. To account for the 
informative censoring of all-cause mortality, we performed a competing risk analysis to 
estimate the associations between rs1051730 T alleles given the outcomes; death, TJR, or end 
of follow-up, according to smoking status. The results were unchanged, which indicates that 
competing risk of all-cause mortality did not explain the association between rs1051730 T 
alleles and risk of TJR.  
 
A key strength of this study is the large sample size and the robust instrumental 
variable (rs1051730) used as a proxy for smoking intensity among current smokers. Our 
longitudinal case ascertainment of TJR through linkage with the nationwide register ensured 
nearly complete data on hip and knee replacements 23,24. A limitation of using TJR as the 
outcome is that it might not indicate the total burden of OA, as indications for replacement 
surgery depend not only on factors related to the disease itself, but also the general health 
status and requirements of the patient as well as the capacity of healthcare. Therefore, we 
acknowledge that the inverse association between smoking and TJR may both include a 
protective effect of smoking on OA as well as a reduced probability of TJR among smokers 
with OA. However, consensus on the diagnosis OA is lacking and only modest agreement has 
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been reported between radiographic, clinical and self-reported methods of diagnosing hip and 
knee OA 37,38. Despite the potential limitation of using TJR as outcome, it does have the 
advantage of being an unambiguous indicator of the disease burden of OA 37. 
Information on smoking status and smoking quantity in HUNT2 was self-reported, 
which makes this exposure prone to misclassification and reporting bias. Furthermore, 
smoking is likely to be associated with survival until time of HUNT2. We therefore cannot 
exclude the possibility of bias from non-participation due to increased mortality among 
smokers. Still, the mean age did not substantially differ by number of rs1051730 T alleles, 
suggesting that the SNP did not substantially affect risk of death prior to baseline. The 
rs1051730 SNP is an instrument of lifetime tobacco exposure that is not fully represented by 
cigarettes smoked per day 14,39. The rs1051730 SNP has been shown to explain the variance in 
serum cotinine (4%), a biomarker of tobacco exposure, better than self-reported cigarettes per 
day (1%) 14, thus supporting the variant as a more accurate measure of smoking intensity. 
However, the rs1051730 SNP is still a valid instrument for smoking even if the self-reports do 
not capture every aspect of the exposure of smoking. We can still provide evidence of 
causality, although we cannot obtain an accurate measure of the effect size of the underlying 
causal exposure 39.  
 
The strength of the Mendelian randomisation approach lies in the use of a randomly assigned 
genotype as a proxy for the modifiable exposure. This method allowed us to overcome many 
of the limitations of a conventional observational study, namely confounding and reversed 
causality 10. However, the approach has its limitations and relies on certain assumptions that 
are only partly testable. First, the genetic variant should be reliably associated with exposure 
40. For rs1051730, the robust relationship with smoking intensity has been confirmed in 
previous genome-wide association studies 11-13 and the association was also substantiated in 
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the current study sample. Second, the genetic variant should only be associated with the 
outcome through the exposure of interest 40. In our cohort, rs1051730 T alleles were only 
associated with TJR in current smokers, which indicates that the effect was mediated through 
smoking intensity. Analysis in broader strata of smoking (never vs. ever) supported the 
interpretation that the association between the rs1051730 T alleles and TJR in current smokers 
was not a result of collider/selection bias only, as the inverse association with TJR remained 
for ever smokers, although weakened. Third, the genetic variant should be independent of 
other factors affecting the outcome (measured and unmeasured confounders) 40. The second 
and third assumptions are impossible to test completely. However, we performed additional 
analyses to assess the robustness of our findings. The results from these analyses supported an 
inverse association between rs1051730 T alleles and TJR among current smokers, 
independent of BMI, cardiovascular comorbidity, and competing risk of all-cause mortality.  
 
To conclude, this Mendelian randomisation analysis indicates a causal role of smoking 
on the risk of TJR. Thus, our study corroborates the inverse association found in previous 
observational studies. The mechanisms underlying a causal association may be related both to 
a protective effect of smoking on OA, and to a reduced likelihood of receiving TJR among 
smokers with OA. The inverse association between smoking and TJR does not support 
smoking as a therapeutic treatment of OA due to the numerous other health hazards related to 
smoking. However, the current findings do emphasize the importance of finding the 
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Table 1. Baseline characteristics of the 55 745 study participants by numbers of rs1051730 T 
alleles. 
  No. of rs1051730 T alleles
 na 0 1 2 p-valueb
Study population – % 55 745 44.3 44.3 11.3  
Smoking – %       
  Never 22 843 42.1 41.2 41.2  
  Former  15 350 28.7 27.7 26.1  
  Current  16 705 29.2 31.1 32.7 <0.001 
No. of cigarettes per dayc – mean 16 034 10.8 11.4 12.1 <0.001 
Age (years) – mean  55 745 49.9 49.8 49.4 0.06 
BMI (kg/m2) – mean 55 395 26.4 26.3 26.3 0.02 
Women – % 29 252 52.3 52.6 53.0 0.52 
Education – %       
  <10 years 37 534 70.1 71.2 70.8  
  10-12 years 4992 9.7 9.2 9.0  
  13 years 10 575 20.2 19.6 20.2 0.08 
Work status – %      
  Unemployed 14 282 26.1 26.2 26.1  
  Employed 40 355 73.9 73.8 73.9 0.90 
Physical activity – %      
  Inactive 4353 9.9 10.0 10.1  
  Light 9134 20.5 21.1 21.1  
  Moderate 16 898 38.7 38.4 38.8  
  High 13 447 31.0 30.6 30.1 0.77 
CVD – % 4335 7.8 7.8 7.4 0.50 
Diabetes – % 1686 3.1 3.0 3.0 0.94 
a  Total n varies from 43,832 to 55,745 due to missing data. 
b Chi-Square test for categorical variables and linear regression for linear associations according to 
number of T alleles.  
c Among current smokers. 
BMI = body mass index, CVD = cardiovascular disease. 
Table 2. Association between rs1051730 T alleles and joint replacement (TJR). 
 All  Never smokers  Former smokers  Current smokers  
 HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value 
Main analysis         
TJR per T allele effecta 0.93 (0.89 to 1.00) 0.04 0.97 (0.89 to 1.06) 0.53 0.97 (0.88 to 1.07) 0.52 0.84 (0.74 to 0.96) 0.008 
Sensitivity analyses         
TJR per T allele effectb 0.94 (0.89 to 1.00) 0.05 0.96 (0.88 to 1.05) 0.36 0.97 (0.88 to 1.08) 0.61 0.87 (0.77 to 0.99) 0.04 
TJR per T allele effectc 0.94 (0.89 to 1.00) 0.04 0.97 (0.89 to 1.06) 0.54 0.97 (0.88 to 1.07) 0.55 0.84 (0.74 to 0.95) 0.007 
TJR per T allele effectd 0.92e (0.87 to 0.98) 0.008 0.97e (0.89 to 1.06) 0.50 0.95e (0.86 to 1.05) 0.29 0.82e (0.73 to 0.93) 0.003 
         
HR=hazard ratio, CI=confidence interval. 
aadjusted for age and sex, n=55 745 (all), n=54 898 (according to smoking status).  
badjusted for age, sex and BMI, n=55 395 (all), n=54 561 (according to smoking status).  
cadjusted for age, sex and CVD, n=55 629 (all), n=54 788 (according to smoking status).  
dcompeting risk analysis accounting for mortality, adjusted for age and sex, no. of deaths among all (n=11 322 of 55 745), never smokers (n=4109 of 22 843), 
former smokers (n=3727 of 15 350) and current smokers (n=3145 of 16 705) 
eestimates are given as subhazard ratios (SHRs).  

 
Figure 1 Age- and sex-adjusted hazard ratios for total joint replacement (hip or knee) with 
95% confidence interval (grey) according to numbers of cigarettes smoked per day. Never and 
former smokers (zero cigarettes a day) are used as reference group.  
 
